Cost-Effectiveness of Lithium Versus an Atypical Anti-Psychotic (AAP) used to Augment Treatment with a Selective Serotonin Reuptake Inhibitor (SSRI) in Treatment Resistant Depression (TRD)
Abstract
Authors
S.J. Edwards L. Nherera N. Trevor V. Wakefield